News BenevolentAI names pharma vet Jörg Möller as its new CEO BenevolentAI’s search for a new chief executive has concluded with the appointment of industry bigwig Dr Jörg Möller to the role, four months after Joanna Shields stepped
Views & Analysis LEO Pharma’s new R&D lead on driving agility in drug develop... After 27 years at Bayer, Jörg Möller has moved to LEO Pharma as the company’s EVP, global research and development.
News Novo Nordisk's dropping share price spells the end for CEO Novo Nordisk's chief executive Lars Fruergaard Jørgensen is stepping down by "mutual agreement" with the company's board.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.